Clinical Trials
80 trialsMK-4280A-007
Merck Sharp & Dohme LLC
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
ALASCCA
Karolinska Institutet
RECITE
Amgen
MK-7902-017
Merck Sharp & Dohme LLC
ALTAIR
National Cancer Center Hospital East
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study
Merck Sharp & Dohme LLC
NEXT-REGIRI
Institut du Cancer de Montpellier - Val d'Aurelle
CheckMate 8HW
Bristol-Myers Squibb
FRESCO-2
Hutchmed
PRESERVE1
G1 Therapeutics, Inc.
LYNK-003
Merck Sharp & Dohme LLC
KEYNOTE-177
Merck Sharp & Dohme LLC
SUNLIGHT
Taiho Oncology, Inc.
RECOURSE
Taiho Oncology, Inc.
COLSTAR
Servier
BEACON CRC
Pfizer
CanStem303C
Sumitomo Pharma America, Inc.
PARADIGM
Takeda
BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma
Canadian Cancer Trials Group
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
NSABP Foundation Inc
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
Eastern Cooperative Oncology Group
OBELICS
National Cancer Institute, Naples
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Amgen
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Amgen
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Alliance for Clinical Trials in Oncology
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
Amgen
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Amgen
POLAR-A
Egetis Therapeutics
POLAR-M
Egetis Therapeutics
COLOPEC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
XCITE
Janssen Research & Development, LLC
Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer
AryoGen Pharmed Co.
TERRA
Taiho Pharmaceutical Co., Ltd.
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer
Alliance for Clinical Trials in Oncology
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Hoffmann-La Roche
TAILOR
Merck KGaA, Darmstadt, Germany
ACP
SWOG Cancer Research Network
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)
Hoffmann-La Roche
INVICTAN®-3
Boehringer Ingelheim
FOXFIREGlobal
Sirtex Medical
A Study in Second Line Metastatic Colorectal Cancer
Eli Lilly and Company
Selenium for Prevention of Adenomatous Colorectal Polyps
University of Arizona
Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
US Oncology Research
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Amgen
NOCT
Norgine
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.
Norgine
MORA
Norgine
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
GlaxoSmithKline